Bionow | News

PharmaKure announces study success for novel blood test to identify biomarkers i...

Oct 17th 2023

Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease

Inspire your next round of molecule design through insightful analysis

Feb 16th 2022

The analysis of new assay data is integral to making the right design decisions in the Design-Make-Test-Analyze (DMTA) cycle. Combining this analysis with computational predictions and the g...

Technology transfer agreement for iiCON validated COVID test will see product us...

Jul 26th 2021

A rapid COVID-19 antigen test, validated through the Infection Innovation Consortium (iiCON), will be used to deliver large-scale testing across Africa as part of a major FIND and UNITAID pr...

Collaboration in COVID-19 testing

Jul 1st 2020

Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces a collaboration agreement with international payments company Caxton and immunity passport app Prova, whi...

CE-IVD mark received for Illumina-based IONA® test

Jul 1st 2020

Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it has received CE-IVD marking for its Illumina-based IONA® test, the Company’s flagship non-inva...

Yourgene COVID-19 testing service launch and business update

May 28th 2020

Manchester, UK – 26 May 2020: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it has expanded its laboratory capabilities to offer COVID-19 testing ser...

MicrosensDx announces a portable coronavirus testing kit for research use that t...

Apr 8th 2020

With the imminent threat of the coronavirus (SARS-CoV-2) forcing countries worldwide into lockdown and putting a severe strain on healthcare services, MicrosensDx has responded by adapting i...

Aptamer Group invite development partners to join us in this endeavour

Apr 6th 2020

Shortened development time for developing a rapid Point of Care COVID-19 test

Innovative synthetic antibody (Aptamer) test for SARS Cov-2 in development at Ap...

Mar 30th 2020

This test will omit the need for lab-based PCR testing for the virus antigen, massively scaling up the number of SARS Cov-2 virus tests that can be conducted in a community setting, partner...

Contract manufacturing agreement for COVID-19 diagnostic test

Mar 27th 2020

Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces the signing of an agreement for contract manufacturing services with Novacyt S.A. (“Novacyt”, EURONEX...

Calling all Bionow Members – can you support the global effort on COVID-19?

Mar 19th 2020

We are keen to hear from any companies who can support the global effort on COVID-19

Arcis Biotechnology Group aiming to raise £2m for prostate cancer testing resea...

Feb 7th 2018

Warrington-based biotech firm Arcis Biotechnology Group is bidding to raise £2m to step up research and development for revolutionary prostate cancer testing.

News